Phase 3 Readout~month
Phase 3 Topline: A Phase 3 Study to Evaluate the Safety and Efficacy of a Single Dose of CTX001 in Pediatric Subjects
- Indication
- Sickle Cell Disease; Hemoglobinopathies; Hydroxyurea Failure
Other upcoming events for VRTX
Phase 3 ReadoutPhase 3 Topline: A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-121/TEZ/D-IVA Combina
Phase 3 ReadoutPhase 3 Topline: A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-121/TEZ/D-IVA Combina
Phase 3 ReadoutPhase 3 Topline: A Phase 3, Open-label Study Evaluating the Long-term Safety and Effectiveness of Suzetrigine in Subj
Phase 3 ReadoutPhase 3 Topline: A Phase 3, Open-label Study Evaluating the Long-term Safety and Effectiveness of Suzetrigine in Subj
Phase 3 ReadoutPhase 3 Topline: A Phase 3, Randomized, Double-blind, Placebo-Controlled Study of the Efficacy and Safety of Suzetrig
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.